AerSale (ASLE) vs Sanara MedTech (SMTI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Sanara MedTech (SMTI) has outperformed AerSale (ASLE) over the past year, gaining 8.4% versus a loss of 38.0%. Over five years, SMTI leads with a +6.3% price change compared with -72.6% for ASLE. Sanara MedTech is the larger company by market cap ($322.2 million vs $241.3 million), about 1.3 times the size.
On valuation, AerSale trades at a lower forward P/E (19.1x vs 64.9x for Sanara MedTech).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ASLE | SMTI |
|---|---|---|
| Share price | $5.06 | $35.07 |
| Market cap | $241.26M | $322.22M |
| 1-day change | +2.74% | +0.06% |
| YTD return | -30.80% | +50.11% |
| 1-year return | -37.96% | +8.41% |
| 5-year return | -72.58% | +6.28% |
| Forward P/E | 19.08 | 64.94 |
| EPS (TTM) | $-0.08 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.04 | $35.34 |
| 52-week low | $4.71 | $16.05 |
| Distance from 52-week high | -37.10% | -0.76% |
| Analyst consensus | none | none |
| Avg. price target upside | +43.42% | -0.20% |
| Average volume | 446.57K | 280.40K |
| Shares outstanding | 47.73M | 9.19M |
| Employees | 704 | 108 |
| Sector | Consumer Discretionary | Health Care |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SMTI has outperformed ASLE by 46.4 percentage points over the past year.
- The two companies sit in different sectors: AerSale in Consumer Discretionary and Sanara MedTech in Health Care.
About AerSale
ASLE stock →AerSale Corporation provides aftermarket commercial aircraft, engines, and its parts to passenger and cargo airlines, leasing companies, original equipment manufacturers, government and defense contractors, and maintenance, repair, and overhaul service providers worldwide. It operates in two segments, Asset Management Solutions and Technical Operations (TechOps).
Consumer Discretionary · Industrial Specialties · 704 employees
About Sanara MedTech
SMTI stock →Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns.
Health Care · Industrial Specialties · 108 employees
ASLE vs SMTI FAQ
Which is bigger, AerSale or Sanara MedTech?
Sanara MedTech (SMTI) is larger, with a market capitalization of $322.22M compared with $241.26M for AerSale (ASLE).
Which stock has performed better over the past year, ASLE or SMTI?
SMTI returned +8.41% over the past 12 months, compared with -37.96% for ASLE (price return, excluding dividends). Past performance does not predict future results.
Are AerSale and Sanara MedTech in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Consumer Discretionary sector.